Impact of novel coronavirus infection COVID-19 on the development of acute kidney injury and peculiarities of chronic kidney disease clinical course: Literature review

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Article discusses the impact of a new coronavirus infection at the kidneys, namely the predictors and mechanism of acute kidney injury (AKI) development, the impact of COVID-19 at chronic renal failure progression. A comparison was made of the severity of the disease, mortality rate, need for ICU treatment and necessity for mechanical ventilation in CKD patients. The results of original studies devoted to these problems are analyzed. The data presented in the article confirm that AKI is one of the most frequent complications of severe course of coronavirus infection, while mechanical ventilation is the main predictor of AKI. Patients with chronic kidney disease have been found to have higher mortality, hospitalization rates, and need for mechanical ventilation in case of COVID-19 than patients without that kind of pathology.

全文:

受限制的访问

作者简介

Veronika Bochkareva

N.S. Karpovich Krasnoyarsk Interdistrict Clinical Emergency Hospital

编辑信件的主要联系方式.
Email: bramma-ska@mail.ru

Pulmonologist

俄罗斯联邦, Krasnoyarsk

Irina Demko

Professor V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Healthcare of Russia

Email: demko64@mail.ru

MD, Professor, Head of the Department of Hospital Therapy and Immunology with a Course of Professional Development

俄罗斯联邦, Krasnoyarsk

Marina Petrova

N.S. Karpovich Krasnoyarsk Interdistrict Clinical Emergency Hospital

Email: stk99@yandex.ru

MD, Professor, Head of the Department of Polyclinic Therapy and Family Medicine with a Course of Professional Development

俄罗斯联邦, Krasnoyarsk

Irina Obukhova

N.S. Karpovich Krasnoyarsk Interdistrict Clinical Emergency Hospital

Email: tolpyga256@gmail.com

Pulmonologist

俄罗斯联邦, Krasnoyarsk

Evgeny Kozlov

N.S. Karpovich Krasnoyarsk Interdistrict Clinical Emergency Hospital

Email: kev-pulmonolog@mail.ru

Head of the Department of Pulmonology

俄罗斯联邦, Krasnoyarsk

参考

  1. Уртаева К. К., Сучков В.Н. Случай новой коронавирусной инфекции COVID-19 у пациента, находящегося на лечении программным гемодиализом. Журнал инфектологии. 2020; 12(3): 94–98. [Urtaeva K.K., Suchkov V.N. A case of a new CoVID-19 coronavirus infection in a patient being treated with programmatic hemodialysis. Zhurnal infektologii = Journal Infectology. 2020; 12(3): 94–98 (In Russ.)]. https://dx.doi.org/10.22625/2072-6732-2020-12-3-94-98. EDN: FECRPY.
  2. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 16 (18.08.2022). Минздрав России. Доступ: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/060/193/original/BMP_COVID-19_V16.pdf (дата обращения – 01.04.2023). [Interim guidelines «Prevention, diagnosis and treatment of novel coronavirus infection (COVID-19)». Version 16 (08/18/2022). Ministry of Healthcare of Russia. URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/060/193/original/BMP_COVID-19_V16.pdf (date of access – 01.04.2023) (In Russ.)].
  3. SARS-CoV-2 Surveillance Group, Istituto Superiore di Sanità (2020) Characteristics of COVID-19 patients dying in Italy.
  4. URL: https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-analysisof-deaths (date of access – 01.04.2023).
  5. Portoles J., Marques M., Lopez-Sanchez P. et al. Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak. Nephrol Dial Transplant. 2020; 35(8): 1353–61. https://dx.doi.org/10.1093/ndt/gfaa189.
  6. Hassanein M., Radhakrishnan Y., Sedor J. et al. COVID-19 and the kidney. Cleve Clin J Med. 2020; 87(10): 619–31. https://dx.doi.org/10.3949/ccjm.87a.20072.
  7. Mohamed M.M., Lukitsch I., Torres-Ortiz A.E. et al. Acute kidney injury associated with coronavirus disease 2019 in urban New Orleans. Kidney360. 2020; 1(7): 614–22. https://dx.doi.org/10.34067/KID.0002652020.
  8. Post A., den Deurwaarder E.S.G., Bakker S.J.L. et al. Kidney infarction in patients with COVID-19. Am J Kidney Dis. 2020; 76(3): 431–35. https://dx.doi.org/10.1053/j.ajkd.2020.05.004.
  9. Noris M., Benigni A., Remuzzi G. The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 2020; 98(2): 314–22. https://dx.doi.org/10.1016/j.kint.2020.05.013.
  10. Cheng Y., Luo R., Wang K. et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020; 97(5): 829–38. https://dx.doi.org/10.1016/j.kint.2020.03.005.
  11. Hirsch J.S., Ng J.H., Ross D.W. et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020; 98(1): 209–18. https://dx.doi.org/10.1016/j.kint.2020.05.006.
  12. Procaccini F.L., Alcazar Arroyo R., Albalate Ramon M. et al. Acute kidney injury in 3182 patients admitted with COVID-19: a single-center, retrospective, case-control study. Clin Kidney J. 2021; 14(6): 1557–69. https://dx.doi.org/10.1093/ckj/sfab021.
  13. Chan L., Chaudhary K., Saha A. et al.; Mount Sinai COVID Informatics Center (MSCIC). AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol. 2021; 32(1): 151–60. https://dx.doi.org/10.1681/ASN.2020050615.
  14. Lee J.R., Silberzweig J., Akchurin O. at al. Characteristics of acute kidney injury in hospitalized COVID-19 patients in an urban Academic Medical Center. Clin J Am Soc Nephrol. 2021; 16(2): 284–86. https://dx.doi.org/10.2215/CJN.07440520.
  15. Столяревич Е.С., Фролова Н.Ф., Артюхина Л.Ю., Варясин В.В. Поражение почек при Covid-19: клинические и морфологические проявления почечной патологии у 220 пациентов, умерших от Covid-19. Нефрология и диализ. 2020; 22(S): 46–55. [Stolyarevich E.S., Frolova N.F., Artyukhina L.Yu., Varyasin V.V. Kidney damage in Covid-19: clinical and morphological manifestations of renal pathology in 220 patients who died from Covid-19. Nephrologiya i dializ = Nephrology and Dialysis. 2020; 22(S): 46–55 (In Russ.)]. EDN: UIBBVU.
  16. Rivero J., Merino-Lopez M., Olmedo R. et al. Association between postmortem kidney biopsy findings and acute kidney injury from patients with SARS-CoV-2 (COVID-19). Clin J Am Soc Nephrol. 2021; 16(5): 685–93. https://dx.doi.org/10.2215/CJN.16281020.
  17. Williamson E.J., Walker A.J., Bhaskaran K. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020; 584(7821): 430–36. https://dx.doi.org/10.1038/s41586-020-2521-4.
  18. Fernandez-Fresnedo G., Ramos M.A., Gonzalez-Pardo M.C. et al. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant. 2000; 15(4): 502–10. https://dx.doi.org/10.1093/ndt/15.4.502.
  19. Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г. с соавт. Регистр «Анализ динамики Коморбидных заболеваний у пациенТов, перенесшИх инфицироВание SARS-CoV-2» (АКТИВ). Оценка влияния комбинаций исходных сопутствующих заболеваний у пациентов с COVID-19 на прогноз. Терапевтический архив. 2022; 94(1): 32–47. [Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G. et al. ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis. Terapevticheskiy arkhiv = Therapeutic Archive. 2022; 94(1): 32–47. https://dx.doi.org/10.26442/00403660.2022.01.201320. EDN: WQMDNC.
  20. Basile C., Combe C., Pizzarelli F. et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020; 35(5): 737–41. https://dx.doi.org/10.1093/ndt/gfaa069.
  21. Xu C., Zhang T., Zhu N., Han M. Characteristics of COVID-19 patients with preexisting CKD history. Int Urol Nephrol. 2021; 53(12): 2567–75. https://dx.doi.org/10.1007/s11255-021-02819-5.
  22. Coca A., Burballa C., Centellas-Perez F.J. et al. Outcomes of COVID-19 among hospitalized patients with non-dialysis CKD. Front Med (Lausanne). 2020; 7: 615312. https://dx.doi.org/10.3389/fmed.2020.615312.
  23. ERA-EDTA Council; ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021; 36(1): 87–94. https://dx.doi.org/10.1093/ndt/gfaa314.
  24. Pakhchanian H., Raiker R., Mukherjee A. et al. Outcomes of COVID-19 in CKD patients: A multicenter electronic medical record cohort study. Clin J Am Soc Nephrol. 2021; 16(5): 785–86. https://dx.doi.org/10.2215/CJN.13820820.
  25. Orieux A., Rubin S., Prevel R. et al. Severe COVID-19-induced AKI: A 3-month follow-up. Clin Kidney J. 2021; 14(4): 1289–90. https://dx.doi.org/10.1093/ckj/sfab028.
  26. Abrishami A., Khalili N., Dalili N. et al. Clinical and radiologic characteristics of COVID-19 in patients with CKD. Iran J Kidney Dis. 2020; 14(4): 267–77.
  27. Ozturk S., Turgutalp K., Arici M. et al. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: A nationwide analysis from Turkey. Nephrol Dial Transplant. 2020; 35(12): 2083–95. https://dx.doi.org/10.1093/ndt/gfaa271.
  28. Kang S.H., Kim S.W., Kim A.Y. et al. Association between chronic kidney disease or acute kidney injury and clinical outcomes in COVID-19 patients. J Korean Med Sci. 2020; 35(50): e434. https://dx.doi.org/10.3346/jkms.2020.35.e434.
  29. Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г. с соавт. Клинические особенности постковидного периода. Результаты международного регистра «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 (АКТИВ SARSCoV-2)». Предварительные данные (6 месяцев наблюдения). Российский кардиологический журнал. 2021; 26(10): 86–98. [Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G. et al. Clinical features of post-COVID-19 period. Results of the international register «Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)». Data from 6-month follow-up. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2021; 26(10): 86–98. https://dx.doi.org/10.15829/1560-4071-2021-4708. EDN: ZAPSJL.
  30. Khatri M., Charytan D.M., Parnia S. et al. Outcomes among hospitalized chronic kidney disease patients with COVID-19. Kidney360. 2021; 2(7): 1107–14. https://dx.doi.org/10.34067/KID.0006852020.
  31. He L., Wei Q., Liu J. et al. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms. Kidney Int. 2017; 92(5): 1071–83. https://dx.doi.org/10.1016/j.kint.2017.06.030.
  32. Munblit D., Nekliudov N.A., Bugaeva P. et al.; StopCOVID Research Team. Stop COVID cohort: An observational study of 3480 patients admitted to the Sechenov University Hospital Network in Moscow City for suspected coronavirus disease 2019 (COVID-19) infection. Clin Infect Dis. 2021; 73(1): 1–11. https://dx.doi.org/10.1093/cid/ciaa1535. Erratum in: Clin Infect Dis. 2021 Jun 26.
  33. Harrison S.L., Fazio-Eynullayeva E., Lane D.A. et al. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis. PLoS Med. 2020; 17(9): e1003321. https://dx.doi.org/10.1371/journal.pmed.1003321.
  34. Henry B.M., Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020; 52(6): 1193–94. https://dx.doi.org/10.1007/s11255-020-02451-9.
  35. Patel D.M., Phadke M., Dai F. et al. Association of AKI-D with urinary findings and baseline eGFR in hospitalized COVID-19 patients. Kidney360. 2021; 2(8): 1215–24. https://dx.doi.org/10.34067/KID.0001612021.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2023
##common.cookie##